Hims & Hers Health (HIMS) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
29 May, 2026Mission and platform overview
Aims to help people feel great through better health by democratizing access to high-quality, personalized care using technology for a seamless customer experience.
Platform leverages data-driven insights, high-touch care, and best-in-class solutions to deliver tailored treatment plans and proactive engagement.
Leadership team includes experienced executives from major tech and healthcare organizations, supporting rapid scaling and innovation.
Market opportunity and expansion
Targets over 100 million potential consumers across specialties and regions, with significant untapped populations in key markets.
Recent and pending acquisitions (Zava, Livewell, Eucalyptus, YourBio) expand reach into Europe, Canada, Australia, and Japan, strengthening international presence.
International revenue grew nearly 10x year-over-year, with further growth expected as new markets are integrated.
Strategic growth levers
Value proposition strengthens with each new subscriber, driven by trusted brand, clinical excellence, and innovative technology.
Focus on deepening personalization, expanding into new specialties, elevating care precision, building strategic relationships, and global platform expansion.
Ecosystem provides value beyond medication, including lab diagnostics, habit tracking, and 24/7 support, fostering long-term customer relationships.
Latest events from Hims & Hers Health
- 2030 targets hinge on global expansion, specialty growth, and AI-driven platform leadership.HIMS
2026 Evercore Global TMT Conference2 Jun 2026 - Q1 2026 revenue up 4% to $608.1M; net loss widened on restructuring, but guidance raised.HIMS
Q1 202618 May 2026 - Proxy covers director elections, auditor ratification, and executive pay, highlighting strong growth and governance.HIMS
Proxy filing28 Apr 2026 - Votes sought for nine directors, auditor ratification, and executive pay at June 2026 meeting.HIMS
Proxy filing28 Apr 2026 - Personalized care, tech-driven growth, and global expansion fuel strong revenue and margin outlook.HIMS
Morgan Stanley Technology, Media & Telecom Conference 20262 Mar 2026 - 2025 revenue up 59% to $2.35B, with strong subscriber and specialty growth, and robust 2026 outlook.HIMS
Q4 202524 Feb 2026 - Q2 revenue up 52% to $315.6M, net income $13.3M, strong subscriber and margin growth.HIMS
Q2 20242 Feb 2026 - Personalized, tech-driven healthcare and GLP-1s fuel rapid growth and operational gains.HIMS
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Directors were elected, auditor ratified, and executive pay approved; results to be filed.HIMS
AGM 20241 Feb 2026